Simplex Trading’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,500
| Closed | -$2K | – | 10242 |
|
|
2023
Q2 | $2K | Hold |
7,500
| – | – | ﹤0.01% | 8531 |
|
|
2023
Q1 | $3K | Sell |
7,500
-12,500
| -63% | -$6.59K | ﹤0.01% | 8389 |
|
|
2022
Q4 | $10K | Sell |
20,000
-5,000
| -20% | -$3.17K | ﹤0.01% | 7593 |
|
|
2022
Q3 | $18K | Sell |
25,000
-2,100
| -8% | -$2.38K | ﹤0.01% | 7655 |
|
|
2022
Q2 | $30K | Sell |
27,100
-8,800
| -25% | -$11.2K | ﹤0.01% | 7176 |
|
|
2022
Q1 | $73K | Sell |
35,900
-16,700
| -32% | -$39.7K | ﹤0.01% | 6607 |
|
|
2021
Q4 | $151K | Sell |
52,600
-900
| -2% | -$3.33K | ﹤0.01% | 5596 |
|
|
2021
Q3 | $286K | Buy |
53,500
+4,000
| +8% | +$17.8K | ﹤0.01% | 4982 |
|
|
2021
Q2 | $261K | Buy |
+49,500
| New | +$238K | ﹤0.01% | 5211 |
|
|
2021
Q1 | – | Sell |
-790
| Closed | -$260K | – | 10352 |
|
|
2020
Q4 | $260K | Buy |
790
+458
| +138% | +$1.74K | ﹤0.01% | 4264 |
|
|
2020
Q3 | $109K | Sell |
332
-518
| -61% | -$1.9K | ﹤0.01% | 4817 |
|
|
2020
Q2 | $286K | Buy |
850
+561
| +194% | +$2.65K | ﹤0.01% | 3588 |
|
|
2020
Q1 | $110K | Sell |
289
-436
| -60% | -$2.02K | ﹤0.01% | 4275 |
|
|
2019
Q4 | $437K | Sell |
725
-498
| -41% | -$3.41K | ﹤0.01% | 2884 |
|
|
2019
Q3 | $924K | Buy |
1,223
+898
| +276% | +$10.1K | ﹤0.01% | 2004 |
|
|
2019
Q2 | $440K | Buy |
325
+152
| +88% | +$1.75K | ﹤0.01% | 2691 |
|
|
2019
Q1 | $93K | Buy |
173
+30
| +21% | +$146 | ﹤0.01% | 4418 |
|
|
2018
Q4 | $42K | Buy |
143
+21
| +17% | +$115 | ﹤0.01% | 4699 |
|
|
2018
Q3 | $99K | Buy |
122
+94
| +336% | +$722 | ﹤0.01% | 4447 |
|
|
2018
Q2 | $27K | Buy |
28
+14
| +100% | +$144 | ﹤0.01% | 5633 |
|
|
2018
Q1 | $1K | Sell |
14
-175
| -93% | -$1.89K | ﹤0.01% | 5867 |
|
|
2017
Q4 | $40K | Sell |
189
-46
| -20% | -$527 | ﹤0.01% | 2662 |
|
|
2017
Q3 | $4K | Sell |
235
-213
| -48% | -$2.25K | ﹤0.01% | 4645 |
|
|
2017
Q2 | $72K | Buy |
448
+112
| +33% | +$2.23K | ﹤0.01% | 2048 |
|
|
2017
Q1 | $102K | Buy |
336
+332
| +8,300% | +$6.6K | ﹤0.01% | 1739 |
|
|
2016
Q4 | $1K | Buy |
+4
| New | +$54 | ﹤0.01% | 5576 |
|
Simplex Trading's ZYNE Position: Q2 2023 in Review
Simplex Trading sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2023, closing a stake of 2,274 shares — an estimated $815 sold.
Simplex Trading first reported a position in ZYNE in Q4 2016 and held it in 13 quarters. The position peaked at $467K in Q1 2017. 41 funds tracked by Wall St. Rank hold ZYNE as of Q2 2023.
- Simplex Trading reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2023 after selling out during the quarter.
- Simplex Trading sold 2,274 Zynerba Pharmaceuticals, Inc shares in Q2 2023, an estimated $815.
- Simplex Trading first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2016 and held it in 13 quarters.
- Simplex Trading's Zynerba Pharmaceuticals, Inc position peaked at $467K in Q1 2017.
- 41 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2023.
Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.